Fourteen-year experience of prenatal diagnosis of Thalassemia in Iran

Community Genetics

Volumn 9, Issue 2, 2006, Pages 93-97

  Najmabadi, Hossein ^a,d   Ghamari, Alireza ^a   Sahebjam, Farhad ^a   Kariminejad, Roxana ^a   Hadavi, Valeh ^a   Khatibi, Talayeh ^a   Samavat, Ashraf ^b   Mehdipour, Elaheh ^a   Modell, Bernadette ^c   Kariminejad, Mohammand Hassan ^a  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d Kariminejad Najmabadi Pathology and Genetics Center   (Iran)

Author keywords

Prenatal diagnosis; Prevention; Screening; Thalassemia; Traits

Indexed keywords

ALLELE; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; ETHNOLOGY; FETUS; GENETIC TRAIT; HEALTH PROGRAM; HETEROZYGOTE; HUMAN; IRAN; LABORATORY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT;

BETA-THALASSEMIA; DNA; FEMALE; HUMANS; IRAN; MUTATION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 33645711639     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091486     Document Type: Article

References (17)

1. Guideline for the Control of Haemoglobin Disorders. Report of the VIth Annual Meeting of the WHO Working Group on Haemoglobinopathies, Cagliari, Sardinia, 8-9 April, 1989. Geneva, World Health Organization, 1989 (unpublished document WHO/HDP/WG/ HA/89.2).
2. WHO Scientific Group: Control of hereditary disorders. WHO Technical Report Series 865. Geneva, WHO, 1996.
3. Nozari G, Rahbar S, Golshaizan A, Ramanzadeh S: Molecular analysis of β-thalassemia in Iran. Hemoglobin 1995;19:425-431.
4. WHO, Community Control of Hereditary Anaemias: Memorandum from a WHO meeting. Bull World Health Organ 1983;61:63-80.
5. Samavat A, Modell B: Iranian national thalassemia screening programme. BMJ 2004;329:1134-1137.
6. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1998;16:1215.
7. Oberkanins C, Moritz A, Kury F: Automated simultaneous analysis of 22 β-globin mutations by reverse-hybridization. Am J Hum Genet 2001;69(suppl):441.
8. Cao A: 1993 William Allan Award Address. Am J Hum Genet 1994;54:397-402.
9. Najmabadi H, Karimi-Nejad R, Sahebjam S: The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001;25:285-296.
10. Mahboudi F, Zenali S, Merat A, et al: The molecular basis of β-thalassemia mutations in Fars province Iran. Irn J Med Sci 1996;21:99-104.
11. Merat A, Haghshenas M, Mostafavi-Pour Z, et al: β-Thalassemia in southwestern Iran. Hemoglobin 1993;17:427-437.
12. Merat A, Nili N: Studies on 22 thalassemic patients from Fars province (South of Iran). Iran J Med Sci 1986;13:28-33.
13. Noori Daloii MR, Moazami N, Farangi S, et al: β-Thalassemia in Iran: A high incidence of the nonsense codon 39 mutation on the island of Queshm. Hemoglobin 1994;18:449-453.
14. Nozari G, Hyman C, Chapman C, Rahbar S: β-Thalassemia alleles found among Iranians living in Southern California. Blood 1990;76:71a.
15. Najmabadi H, Teimourian S, Khatibi T, et al: Amplification refractory mutation system (ARMS) and reverse hybridization in detection of β-thalassemia mutations. Arch Irn Med 2001;4:165-170.
16. Weatherall DJ, Clegg JB: Thalassemia - a global public health problem. Nat Med 1996;2:847-849.
17. Cao A, Galanello R, Rosatelli MC: Prenatal diagnosis and screening of the haemoglobinopathies. Baillieres Clin Haemotol 1998;11:185-214.